Agar de capa delgada: Una opción costo-efectiva para el diagnóstico rápido de tuberculosis multirresistente

Hernández-Sarmiento, José M.; Martínez-Negrete, Milton A.; Castrillón-Velilla, Diana M.; Mejía-Espinosa, Sergio A.; Mejía-Mesa, Gloria I.; Zapata-Fernández, Elsa M.; Rojas-Jiménez, Sara; Marín-Castro, Andrés E.; Robledo-Restrepo, Jaime A..
Rev. salud pública ; 16(1): 90-102, ene.-feb. 2014. ilus, tab
Artículo en Español | LILACS | ID: lil-717114

Documentos relacionados

  1. [Thin layer agar represents a cost-effective alternative for the rapid diagnosis of multi-drug resistant tuberculosis].
  2. What causes high costs for rural tuberculosis inpatients? Evidence from five counties in China.
  3. Feasibility and cost analysis of programmatic implementation of Microscopic-Observation Drug Susceptibility (MODS) assay in Nigeria.
  4. Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial.
  5. Direct and indirect patient costs of tuberculosis care in India.
  6. Tuberculosis cost in tunisia.
  7. Cost-effectiveness study of the microbiological diagnosis of tuberculosis using geneXpert MTB/RIF<sup>®</sup>.
  8. Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
  9. Cost-optimization in the treatment of multidrug resistant tuberculosis in Nigeria.
  10. Cost of three models of care for drug-resistant tuberculosis patients in Nigeria.